Table 3.
Reported Denominator and Performance for ABCS Measures within H2N and Standardized Comparison Submission.
| eCQM Measure | H2N submissions (N = 191 practices) | Comparison submissions (N = 3 practices) | ||||||
|---|---|---|---|---|---|---|---|---|
| Denominator Mean (range)1 | Performance Mean (Standard) | Performance Mean (Non-standard) | Delta2 | Denominator Mean (range) | Performance Mean (Standard) | Performance Mean (Non-standard) | Delta | |
| Use of aspirin (CMS164) | 262.13 (1–2939) |
70.3% (N = 320) |
64.8% (N = 143) |
5.5% | 778.675 (229–1154) |
76.09% (N = 10) |
75.51% (N = 30) |
.58% |
| Controlling high blood pressure (CMS 165) | 962.44 (5–7810) |
61.3% (N = 364) |
64.6% (N = 164) |
–3.3% | 1983.4 (698–2770) |
62.15% (N = 10) |
63.70% (N = 30) |
–1.55% |
| Cholesterol Management by Statin Therapy (CMS 347) | 562.50 (2–3070) |
68.9% (N = 111) |
54.7% (N = 126) |
14.2% | 1301.85 (487–1797) |
68.64% (N = 10) |
69.37% (N = 30) |
–.73% |
| Tobacco cessation intervention (CMS138) | 2041.61 (6–22699) |
71.2% (N = 316) |
71.7% (N = 149) |
–.5% | 7071.5 (2854–10599) |
70.91% (N = 7) |
71.62% (N=21) |
–.71% |
1 Denominator Mean (range): The average number of patients reported per measure across both standard and non-standard measurement periods.
2 Delta: The difference in performance mean between the standard and non-standard measurement periods.